Fidelity Investments’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-94
Closed -$2.27K 5502
2025
Q4
$2.27K Buy
94
+71
+309% +$1.72K ﹤0.01% 5001
2025
Q3
$567 Buy
+23
New +$553 ﹤0.01% 5074
2025
Q1
Sell
-1
Closed -$23 5489
2024
Q4
$23 Hold
1
﹤0.01% 5347
2024
Q3
$24 Buy
+1
New +$24 ﹤0.01% 5316
2021
Q4
Sell
-1
Closed 4632
2021
Q3
$0 Buy
+1
New +$26 ﹤0.01% 4666

Other funds holding IBD

Fidelity Investments's IBD Position: Q1 2026 in Review

Fidelity Investments sold out of Inspire Corporate Bond ETF (IBD) in Q1 2026, closing a stake of 94 shares — an estimated $2.27K sold.

Fidelity Investments first reported a position in IBD in Q3 2021 and held it in 5 quarters. The position peaked at $2.27K in Q4 2025. 106 funds tracked by Wall St. Rank hold IBD as of Q1 2026.

  • Fidelity Investments reported no remaining Inspire Corporate Bond ETF position as of Q1 2026 after selling out during the quarter.
  • Fidelity Investments sold 94 Inspire Corporate Bond ETF shares in Q1 2026, an estimated $2.27K.
  • Fidelity Investments first reported a position in Inspire Corporate Bond ETF in Q3 2021 and held it in 5 quarters.
  • Fidelity Investments's Inspire Corporate Bond ETF position peaked at $2.27K in Q4 2025.
  • 106 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.